Helicobacter pylori resistens

Jalal Alimoradi; Lone Rasmussen; Leif Percival Andersen

Helicobacter pylori resistens

Jalal Alimoradi, Lone Rasmussen, Leif Percival Andersen

Department of Clinical Medicine

2 Citations (Scopus)

Abstract

Helicobacter pylori (H. pylori) is recognized as the causative of several gastroduodenal disorders. The discovery of H. pylori revolutionized the treatment for ulcus pepticum. Antibiotics combined with proton pump inhibitors or bismuth have been effective in the treatment of H. pylori infections, but there is an emerging problem with H. pylori resistance against the most frequently used antibiotics, which substantially impairs the treatment of H. pylori -associated disorders. In this article the focus is on the prevalence of H. pylori resistance, its clinical implications and the molecular mechanisms behind resistance development.

Original language	Danish
Journal	Ugeskrift for Laeger
Volume	172
Pages (from-to)	1516-1521
Number of pages	6
ISSN	0041-5782
Publication status	Published - May 2010

Cite this

@article{856f8ca07a454e97ab6128a8c657058c,

title = "Helicobacter pylori resistens",

abstract = "Helicobacter pylori (H. pylori) is recognized as the causative of several gastroduodenal disorders. The discovery of H. pylori revolutionized the treatment for ulcus pepticum. Antibiotics combined with proton pump inhibitors or bismuth have been effective in the treatment of H. pylori infections, but there is an emerging problem with H. pylori resistance against the most frequently used antibiotics, which substantially impairs the treatment of H. pylori -associated disorders. In this article the focus is on the prevalence of H. pylori resistance, its clinical implications and the molecular mechanisms behind resistance development.",

author = "Jalal Alimoradi and Lone Rasmussen and Andersen, {Leif Percival}",

year = "2010",

month = may,

language = "Dansk",

volume = "172",

pages = "1516--1521",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

}

TY - JOUR

T1 - Helicobacter pylori resistens

AU - Alimoradi, Jalal

AU - Rasmussen, Lone

AU - Andersen, Leif Percival

PY - 2010/5

Y1 - 2010/5

N2 - Helicobacter pylori (H. pylori) is recognized as the causative of several gastroduodenal disorders. The discovery of H. pylori revolutionized the treatment for ulcus pepticum. Antibiotics combined with proton pump inhibitors or bismuth have been effective in the treatment of H. pylori infections, but there is an emerging problem with H. pylori resistance against the most frequently used antibiotics, which substantially impairs the treatment of H. pylori -associated disorders. In this article the focus is on the prevalence of H. pylori resistance, its clinical implications and the molecular mechanisms behind resistance development.

AB - Helicobacter pylori (H. pylori) is recognized as the causative of several gastroduodenal disorders. The discovery of H. pylori revolutionized the treatment for ulcus pepticum. Antibiotics combined with proton pump inhibitors or bismuth have been effective in the treatment of H. pylori infections, but there is an emerging problem with H. pylori resistance against the most frequently used antibiotics, which substantially impairs the treatment of H. pylori -associated disorders. In this article the focus is on the prevalence of H. pylori resistance, its clinical implications and the molecular mechanisms behind resistance development.

M3 - Tidsskriftartikel

SN - 0041-5782

VL - 172

SP - 1516

EP - 1521

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

ER -